Chronic Myeloid Leukemia (CML) Real-Life Database

NCT05963061 · tracked via the Priya Life Science France tracker

Sponsor

University Hospital, Clermont-Ferrand

Phase

Observational

Started

2014-04-16

Last updated

2024-04-09

Condition(s) studied

Chronic Myeloid Leukemia (CML)

Study summary

Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient diagnosed for chronic myelocytic leukemia Exclusion Criteria: * CML allograft without TKI treatment * Refusal or inability to sign the consent

Primary outcome measure(s)

Clinical and biological data collection — Until death or last follow up (up to 30 years)
Aims of the registry are the collection of clinical data to gain further insights about patients's CML treated with ITK's (treatment, prognosis, therapeutical response).

Trial sites (14)

Facility	City	Region	Status
CH Annecy Genevois	Annecy	France	Recruiting
University Hospital, Caen	Caen	France	Recruiting
CHU Clemront-Ferrand	Clermont-Ferrand	France	Recruiting
Centre Hospitalier Emile Roux	Le Puy-en-Velay	France	Recruiting
University Hospital, Limoges	Limoges	France	Recruiting
Institut Paoli-Calmettes	Marseille	France	Recruiting
Centre Hospital, Nancy	Nancy	France	Recruiting
Bicetre Hospital	Paris	France	Recruiting
Hopital Paul Brousse	Paris	France	Recruiting
Rennes University Hospital	Rennes	France	Recruiting
Centre Hospitalier de Rochefort	Rochefort	France	Recruiting
Centre Hospitalier Universitaire de Saint Etienne	Saint-Etienne	France	Recruiting
University Hospital, Toulouse	Toulouse	France	Recruiting
Versailles Hospital	Versailles	France	Recruiting

More University Hospital, Clermont-Ferrand trials in France

Importance of the Type of Communication Used During Paraapical Anesthesia in Dentistry Recruiting

Optimization of a Non-invasive Electrophysiological Method for Studying the Functionality of Auditory Nerve Fibers Recruiting

Exploration of High Frequency Otoacoustic Emissions and Developmental Language Disorders Starting soon

QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up Recruiting

Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome Recruiting

Other trials for the same condition

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. Recruiting

Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial Enrolling by invitation

Second STOP After Pioglitazone Priming in CML Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05963061 on ClinicalTrials.gov ↗ ← All trials in France